Has John Rice, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,583 in general payments to John Rice, MD across 103 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Rice, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Rice, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Rice, MD

Internal Medicine · Hazelwood, MONPI 1821079492

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $920 and has fallen 89.5% since, to $97 in 2025.

$1,583in general payments, 2019–2025

Across 103 payments — averaging $15.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$306
Lilly USA, LLC$247
GSK$183
Medtronic$116
Sanofi-aventis U.S. LLC$112
Boehringer Ingelheim$106
plus $513 from 15 others

What the payments were for

Food & beverage$1,583100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	23	$306
Lilly USA, LLC	17	$247
GSK	14	$183
Medtronic(2 entities)	2	$116
Sanofi-aventis U.S. LLC	7	$112
Boehringer Ingelheim	7	$106
AbbVie(2 entities)	5	$75
Tris Pharma Inc	5	$71
Grifols USA, LLC	3	$50
Merck	3	$47
Kowa Pharmaceuticals America, Inc.	3	$43
E.r. Squibb & Sons, L.L.C.	2	$35
Bristol Myers Squibb	1	$33
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$30
Sandoz	2	$28
Novartis	2	$24
Genentech USA, Inc.	1	$19
Ironshore Pharmaceuticals Inc.	1	$17
Amarin Pharma, Inc.	1	$15
Exact Sciences	1	$14
Novo Nordisk	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENDURANT IIS$104

How this compares

$1,583 in reported general payments places this provider in the 75th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri →

Medicare billing

Part B allowed, 2024

$9,357

Medicare patients

Services billed

242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	11	$9,023
Metoprolol Succinate	37	$671
Amlodipine Besylate	91	$663
Atorvastatin Calcium	68	$609
Losartan Potassium	31	$424
Levothyroxine Sodium	22	$346
Omeprazole	39	$343
Furosemide	32	$283
Albuterol Sulfate HfaAlbuterol Sulfate	11	$241
Lisinopril	32	$234
Meloxicam	28	$216
Pantoprazole Sodium	18	$215
Metformin Hcl	19	$192
Tamsulosin Hcl	16	$181
Simvastatin	23	$177

Paid to pharmacies, not to this prescriber.

Other internal medicine in Hazelwood

Timothy SmithSaint Peters$428K
Craig DietzKansas City$226K
Kevin SuttmoellerKansas City$198K
Vinay KamatSaint Louis$191K
David PrelutskySaint Louis$182K
Dima DandachiColumbia$157K
Justin SteinkampSaint Charles$139K
Tracy NorfleetSaint Louis$132K
Paul OlivoSaint Louis$98K
William SummersSaint Louis$93K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →